229 related articles for article (PubMed ID: 36763294)
1. Butyrate: More Than a Short Chain Fatty Acid.
Mohamed Elfadil O; Mundi MS; Abdelmagid MG; Patel A; Patel N; Martindale R
Curr Nutr Rep; 2023 Jun; 12(2):255-262. PubMed ID: 36763294
[TBL] [Abstract][Full Text] [Related]
2. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.
Kibbie JJ; Dillon SM; Thompson TA; Purba CM; McCarter MD; Wilson CC
Immunobiology; 2021 Sep; 226(5):152126. PubMed ID: 34365090
[TBL] [Abstract][Full Text] [Related]
3. Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome.
Bridgeman SC; Northrop W; Melton PE; Ellison GC; Newsholme P; Mamotte CDS
Pharmacol Res; 2020 Oct; 160():105174. PubMed ID: 32860943
[TBL] [Abstract][Full Text] [Related]
4. A major mechanism for immunomodulation: Dietary fibres and acid metabolites.
Xie L; Alam MJ; Marques FZ; Mackay CR
Semin Immunol; 2023 Mar; 66():101737. PubMed ID: 36857894
[TBL] [Abstract][Full Text] [Related]
5. A new paradigm for a new simple chemical: butyrate & immune regulation.
Dang G; Wu W; Zhang H; Everaert N
Food Funct; 2021 Dec; 12(24):12181-12193. PubMed ID: 34752597
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of nutritional short-chain fatty acids (SCFAs) against cancer via modulation of hematopoiesis.
Thiruvengadam M; Subramanian U; Venkidasamy B; Thirupathi P; Samynathan R; Shariati MA; Rebezov M; Chung IM; Rengasamy KRR
Crit Rev Food Sci Nutr; 2023; 63(6):827-844. PubMed ID: 34319824
[TBL] [Abstract][Full Text] [Related]
7. Short-chain fatty acid-mediated epigenetic modulation of inflammatory T cells in vitro.
McBride DA; Dorn NC; Yao M; Johnson WT; Wang W; Bottini N; Shah NJ
Drug Deliv Transl Res; 2023 Jul; 13(7):1912-1924. PubMed ID: 36566262
[TBL] [Abstract][Full Text] [Related]
8. Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate.
Sim JR; Kang SS; Lee D; Yun CH; Han SH
Front Immunol; 2018; 9():55. PubMed ID: 29434590
[TBL] [Abstract][Full Text] [Related]
9. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
Sivaprakasam S; Prasad PD; Singh N
Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
[TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylase Inhibition by Gut Microbe-Generated Short-Chain Fatty Acids Entrains Intestinal Epithelial Circadian Rhythms.
Fawad JA; Luzader DH; Hanson GF; Moutinho TJ; McKinney CA; Mitchell PG; Brown-Steinke K; Kumar A; Park M; Lee S; Bolick DT; Medlock GL; Zhao JY; Rosselot AE; Chou CJ; Eshleman EM; Alenghat T; Hong CI; Papin JA; Moore SR
Gastroenterology; 2022 Nov; 163(5):1377-1390.e11. PubMed ID: 35934064
[TBL] [Abstract][Full Text] [Related]
11. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
13. The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases.
Pant K; Venugopal SK; Lorenzo Pisarello MJ; Gradilone SA
Am J Pathol; 2023 Oct; 193(10):1455-1467. PubMed ID: 37422149
[TBL] [Abstract][Full Text] [Related]
14. Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion.
Zhuang M; Shang W; Ma Q; Strappe P; Zhou Z
Mol Nutr Food Res; 2019 Dec; 63(23):e1801187. PubMed ID: 31556210
[TBL] [Abstract][Full Text] [Related]
15. Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition.
Korsten SGPJ; Peracic L; van Groeningen LMB; Diks MAP; Vromans H; Garssen J; Willemsen LEM
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409339
[TBL] [Abstract][Full Text] [Related]
16. The Role of Short-Chain Fatty Acids in Acute Pancreatitis.
Yan X; Li J; Wu D
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446647
[TBL] [Abstract][Full Text] [Related]
17. Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease.
Wang S; Lv D; Jiang S; Jiang J; Liang M; Hou F; Chen Y
Clin Sci (Lond); 2019 Sep; 133(17):1857-1870. PubMed ID: 31467135
[TBL] [Abstract][Full Text] [Related]
18. Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.
Bach Knudsen KE; Lærke HN; Hedemann MS; Nielsen TS; Ingerslev AK; Gundelund Nielsen DS; Theil PK; Purup S; Hald S; Schioldan AG; Marco ML; Gregersen S; Hermansen K
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30322146
[TBL] [Abstract][Full Text] [Related]
19. Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways.
Chen J; Zhao KN; Vitetta L
Nutrients; 2019 May; 11(5):. PubMed ID: 31067776
[TBL] [Abstract][Full Text] [Related]
20. Production, Structural Characterization, and In Vitro Assessment of the Prebiotic Potential of Butyl-Fructooligosaccharides.
Kang S; You HJ; Lee YG; Jeong Y; Johnston TV; Baek NI; Ku S; Ji GE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
